FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

13407511000001108: Altargo 1% ointment (GlaxoSmithKline) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
47289401000001113 Altargo 1% ointment (GlaxoSmithKline) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
69183001000001115 Altargo 10mg/g ointment (GlaxoSmithKline UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Altargo 1% ointment (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Altargo 1% ointment (GlaxoSmithKline) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Altargo 1% ointment (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Altargo 1% ointment (GlaxoSmithKline) Is a Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment true Inferred relationship Existential restriction modifier
Altargo 1% ointment (GlaxoSmithKline) Has active ingredient Retapamulin false Inferred relationship Existential restriction modifier
Altargo 1% ointment (GlaxoSmithKline) Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Altargo 1% ointment (GlaxoSmithKline) Has excipient Butylated hydroxytoluene false Inferred relationship Existential restriction modifier
Altargo 1% ointment (GlaxoSmithKline) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Altargo 1% ointment (GlaxoSmithKline) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Altargo 1% ointment (GlaxoSmithKline) Is a Altargo true Inferred relationship Existential restriction modifier
Altargo 1% ointment (GlaxoSmithKline) Has specific active ingredient Retapamulin true Inferred relationship Existential restriction modifier
Altargo 1% ointment (GlaxoSmithKline) Has dispensed dose form Ointment true Inferred relationship Existential restriction modifier
Altargo 1% ointment (GlaxoSmithKline) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Altargo 1% ointment (GlaxoSmithKline) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Altargo 1% ointment (GlaxoSmithKline) 5 gram Is pack of False Altargo 1% ointment (GlaxoSmithKline) Inferred relationship Existential restriction modifier
Altargo 1% ointment (GlaxoSmithKline) 5 gram Has AMP True Altargo 1% ointment (GlaxoSmithKline) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start